These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
    Author: Mowry SE, Strocker AM, Chan J, Takehana C, Kalantar N, Bhuta S, Shapiro NL.
    Journal: Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437.
    Abstract:
    OBJECTIVE: To compare lymphocyte immunohistochemical markers and staining for Epstein-Barr virus (EBV) in tonsillectomy specimens from healthy children and pediatric transplant recipients. DESIGN: Analysis of pathology specimens. SETTING: Tertiary care medical center. PATIENTS: Consecutive sample of tonsillectomy specimens from 60 pediatric solid organ transplant recipients and 60 healthy children. INTERVENTION: Immunohistochemical staining of tonsillectomy specimens for kappa and lambda light chains, B and T lymphocytes, EBV-encoded small nuclear RNA (EBV-EBER), and EBV-encoded latent membrane protein (EBV-LMP). MAIN OUTCOME MEASURE: Detection of a difference in EBV activity in transplant recipients vs healthy controls. RESULTS: There was 1 case of posttransplantation lymphoproliferative disorder (PTLD). All other tonsillectomy specimens from both groups demonstrated follicular hyperplasia. Tonsillectomy specimens from both groups were polyclonal, expressing kappa and lambda light-chain activity, including the case of PTLD. The number of specimens staining positive for CD3 activity, a marker of T lymphocytes, was reduced in the transplant group (85%), compared with 100% in the control group (P < .01). EBV-EBER is a nuclear stain indicating active EBV infection, whereas EBV-LMP staining denotes latent infection. Twenty-seven of 60 transplant specimens (45%) demonstrated EBV-EBER activity compared with 0 of 60 control specimens (P < .001). EBV-LMP activity was equal in both groups. CONCLUSIONS: Adenotonsillar hypertrophy in transplant recipients with no prior exposure to EBV may be a sign of active EBV infection. A high incidence of EBV-EBER was found in the tonsils of transplant recipients. Active adenotonsillar EBV infection in the setting of T-lymphocyte suppression in transplant recipients may be a potential early precursor of PTLD.
    [Abstract] [Full Text] [Related] [New Search]